About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
E2f2tm1Zubi
targeted mutation 1, Ana Zubiaga
MGI:2179111
Summary 7 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
E2f2tm1Zubi/E2f2tm1Zubi involves: 129S1/Sv * C57BL/6 MGI:3723019
cn2
E2f2tm1Zubi/E2f2tm1Zubi
Rbl1tm1Htr/Rbl1tm1Htr
Tg(Pax6-cre,GFP)2Pgr/?
involves: 129 * C57BL/6 * FVB/N * NMRI MGI:3722916
cx3
E2f1tm1Meg/E2f1tm1Meg
E2f2tm1Zubi/E2f2tm1Zubi
E2f3tm2.1Gle/E2f3tm2.1Gle
involves: 129 * FVB/N * NIH Black Swiss MGI:3806839
cx4
E2f1tm1Meg/E2f1tm1Meg
E2f2tm1Zubi/E2f2tm1Zubi
E2f3tm3.1Gle/E2f3tm3.1Gle
involves: 129 * FVB/N * NIH Black Swiss MGI:3806840
cx5
E2f2tm1Zubi/E2f2tm1Zubi
E2f3tm2.1Gle/E2f3tm2.1Gle
involves: 129S1/Sv * 129S6/SvEvTac * FVB/N * NIH Black Swiss MGI:3806843
cx6
E2f2tm1Zubi/E2f2tm1Zubi
E2f3tm3.1Gle/E2f3tm3.1Gle
involves: 129S1/Sv * 129S6/SvEvTac * FVB/N * NIH Black Swiss MGI:3806845
cx7
E2f2tm1Zubi/E2f2tm1Zubi
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2J MGI:3723020


Genotype
MGI:3723019
hm1
Allelic
Composition
E2f2tm1Zubi/E2f2tm1Zubi
Genetic
Background
involves: 129S1/Sv * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
E2f2tm1Zubi mutation (1 available); any E2f2 mutation (29 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• at 15 months, only 27% of mice are alive compared to 67% of wild-type mice

immune system
• at 15 months, mice exhibit splenomegaly with spleen size 2 to 5 times greater than that of wild-type mice
• at week 8 to 12, spleen weight is increased 2-fold (1445+/-250 mg) relative to in wild-type mice (668+/-108 mg) and continues to increase at 15 months (3340+/-540 mg compared to 722+/-125 mg in wild-type mice)
• the fraction of mature (CD4+ and, especially, CD8+) thymocytes in the thymus is increased with a decreased in immature double positive thymocytes
• there is an increase in the number of CD8+ T cells relative to CD4+ T cells (CD4+/CD8+ ratio: 0.79+/-0.1 compared to 1.43+/-0.3 in wild-type mice)
• however, the T to B cells ratio is normal
• at 3 to 4 weeks and at 15 months, the number of CD44hiCD69- memory T cells is increased
• at 15 months, mice display white pulp hyperplasia and increased sinusoidal cellularity
• in response to IL-2 treatment, effector/memory cell (CD44hiCD69-) T cell proliferation is increased relative to in wild-type mice by 2 times at weeks 8 to 12, and 13 times at 15 months
• T cell proliferation stimulated by CD3 antibody is increased compared to in stimulated wild-type mice and is more prominent at suboptimal CD3 antibody concentrations
• at 15 months, mice exhibit features of autoimmune disease including inflammatory infiltrate, adnormal accumulation of effector/memory T cells, and double stranded DNA antibodies
• the amount of double stranded DNA antibodies is increased relative to in wild-type mice and corresponds to the severity of organ damage
• at 15 months, mice exhibit features of autoimmune disease
• in elderly mice, increased mononuclear infiltrate is observed in the lung, kidney and liver
• in elderly mice, inflammatory infiltrate accumulates in the liver and perivascular infiltrates are observed
• elderly mice exhibit membranoproliferative glomerulonephritis that is focal and of moderate intensity
• affected glomeruli are enlarged with a thickened basement membrane and contain perivascular aggregates of inflammatory infiltrate and immune complex deposition
• in elderly mice, inflammatory infiltrate accumulates in the lung

liver/biliary system
• in elderly mice, inflammatory infiltrate accumulates in the liver and perivascular infiltrates are observed

renal/urinary system
• elderly mice exhibit membranoproliferative glomerulonephritis that is focal and of moderate intensity
• affected glomeruli are enlarged with a thickened basement membrane and contain perivascular aggregates of inflammatory infiltrate and immune complex deposition
• affected glomeruli display a thickened basement membrane
• affected glomeruli are enlarged

respiratory system
• in elderly mice, inflammatory infiltrate accumulates in the lung

hematopoietic system
• in response to IL-2 treatment, effector/memory cell (CD44hiCD69-) T cell proliferation is increased relative to in wild-type mice by 2 times at weeks 8 to 12, and 13 times at 15 months
• T cell proliferation stimulated by CD3 antibody is increased compared to in stimulated wild-type mice and is more prominent at suboptimal CD3 antibody concentrations
• at 15 months, mice exhibit splenomegaly with spleen size 2 to 5 times greater than that of wild-type mice
• at week 8 to 12, spleen weight is increased 2-fold (1445+/-250 mg) relative to in wild-type mice (668+/-108 mg) and continues to increase at 15 months (3340+/-540 mg compared to 722+/-125 mg in wild-type mice)
• the fraction of mature (CD4+ and, especially, CD8+) thymocytes in the thymus is increased with a decreased in immature double positive thymocytes
• there is an increase in the number of CD8+ T cells relative to CD4+ T cells (CD4+/CD8+ ratio: 0.79+/-0.1 compared to 1.43+/-0.3 in wild-type mice)
• however, the T to B cells ratio is normal
• at 3 to 4 weeks and at 15 months, the number of CD44hiCD69- memory T cells is increased
• at 15 months, mice display white pulp hyperplasia and increased sinusoidal cellularity

cellular
• adenovirus-Myc fails to induce S phase as it does in wild-type mouse embryonic fibroblasts
• cell death induced by Myc expression in primary fibroblast cells is somewhat less efficient than in wild-type primary fibroblast
• in response to IL-2 treatment, effector/memory cell (CD44hiCD69-) T cell proliferation is increased relative to in wild-type mice by 2 times at weeks 8 to 12, and 13 times at 15 months
• T cell proliferation stimulated by CD3 antibody is increased compared to in stimulated wild-type mice and is more prominent at suboptimal CD3 antibody concentrations

integument
• elderly mice exhibit considerable hair loss
• elderly mice exhibit skin wounds
• elderly mice exhibit erythema affecting the head and neck

growth/size/body
• at 15 months, mice exhibit splenomegaly with spleen size 2 to 5 times greater than that of wild-type mice
• at week 8 to 12, spleen weight is increased 2-fold (1445+/-250 mg) relative to in wild-type mice (668+/-108 mg) and continues to increase at 15 months (3340+/-540 mg compared to 722+/-125 mg in wild-type mice)




Genotype
MGI:3722916
cn2
Allelic
Composition
E2f2tm1Zubi/E2f2tm1Zubi
Rbl1tm1Htr/Rbl1tm1Htr
Tg(Pax6-cre,GFP)2Pgr/?
Genetic
Background
involves: 129 * C57BL/6 * FVB/N * NMRI
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
E2f2tm1Zubi mutation (1 available); any E2f2 mutation (29 available)
Rbl1tm1Htr mutation (0 available); any Rbl1 mutation (60 available)
Tg(Pax6-cre,GFP)2Pgr mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
vision/eye
• apoptosis eliminates most retinal ganglion cells as in Rbl1 null mice
• apoptosis eliminates many rod cells as in Rbl1 null mice
• apoptosis eliminates most bipolar cells as in Rbl1 null mice
• retinal transition cells (RTC) undergo ectopic cell divisions as in Rbl1 null mice

nervous system
• apoptosis eliminates most retinal ganglion cells as in Rbl1 null mice
• apoptosis eliminates many rod cells as in Rbl1 null mice
• apoptosis eliminates most bipolar cells as in Rbl1 null mice




Genotype
MGI:3806839
cx3
Allelic
Composition
E2f1tm1Meg/E2f1tm1Meg
E2f2tm1Zubi/E2f2tm1Zubi
E2f3tm2.1Gle/E2f3tm2.1Gle
Genetic
Background
involves: 129 * FVB/N * NIH Black Swiss
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
E2f1tm1Meg mutation (2 available); any E2f1 mutation (25 available)
E2f2tm1Zubi mutation (1 available); any E2f2 mutation (29 available)
E2f3tm2.1Gle mutation (0 available); any E2f3 mutation (32 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging

cellular
• in MEFs after 5 and 6 days in culture compared to littermate-derived controls




Genotype
MGI:3806840
cx4
Allelic
Composition
E2f1tm1Meg/E2f1tm1Meg
E2f2tm1Zubi/E2f2tm1Zubi
E2f3tm3.1Gle/E2f3tm3.1Gle
Genetic
Background
involves: 129 * FVB/N * NIH Black Swiss
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
E2f1tm1Meg mutation (2 available); any E2f1 mutation (25 available)
E2f2tm1Zubi mutation (1 available); any E2f2 mutation (29 available)
E2f3tm3.1Gle mutation (0 available); any E2f3 mutation (32 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
N
• unlike triple mutant mice lacking expression of the E2f3a isoform, triple mutant mice lacking the E2f3b isoform survive to adulthood

cellular
• in MEFs after 5 and 6 days in culture compared to littermate-derived controls

growth/size/body




Genotype
MGI:3806843
cx5
Allelic
Composition
E2f2tm1Zubi/E2f2tm1Zubi
E2f3tm2.1Gle/E2f3tm2.1Gle
Genetic
Background
involves: 129S1/Sv * 129S6/SvEvTac * FVB/N * NIH Black Swiss
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
E2f2tm1Zubi mutation (1 available); any E2f2 mutation (29 available)
E2f3tm2.1Gle mutation (0 available); any E2f3 mutation (32 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• born at the expected frequency, normal birth weights and mature without obvious defects




Genotype
MGI:3806845
cx6
Allelic
Composition
E2f2tm1Zubi/E2f2tm1Zubi
E2f3tm3.1Gle/E2f3tm3.1Gle
Genetic
Background
involves: 129S1/Sv * 129S6/SvEvTac * FVB/N * NIH Black Swiss
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
E2f2tm1Zubi mutation (1 available); any E2f2 mutation (29 available)
E2f3tm3.1Gle mutation (0 available); any E2f3 mutation (32 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• develop normally and have a normal lifespan




Genotype
MGI:3723020
cx7
Allelic
Composition
E2f2tm1Zubi/E2f2tm1Zubi
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
Genetic
Background
involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
E2f2tm1Zubi mutation (1 available); any E2f2 mutation (29 available)
Tg(TcraH-Y,TcrbH-Y)71Vbo mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• male mice die at 5 to 7 months of age after falling ill at 4 months of age whereas Tg(TcraH-Y,TcrbH-Y)71Vbo mice remain healthy and live at least 12 months

immune system
• cell number within the thymus in male mice is decreased to a similar extent as in Tg(TcraH-Y,TcrbH-Y)71Vbo mice
• however, thymic negative selection is normal
• in male mice
• the proportion of H-Y-specific CD8+ T cells is increased 2- to 3-fold
• Vbeta8+/CD8+ T cell proliferation is increased
• at 5 months, male mice exhibit features of inflammatory/autoimmune disease that are more severe than those observed at 15 months in E2f2tm1Zubi homozygotes
• at 5 months, male mice exhibit features of inflammatory/autoimmune disease that are more severe than those observed at 15 months in E2f2tm1Zubi homozygotes

hematopoietic system
• Vbeta8+/CD8+ T cell proliferation is increased
• cell number within the thymus in male mice is decreased to a similar extent as in Tg(TcraH-Y,TcrbH-Y)71Vbo mice
• however, thymic negative selection is normal
• in male mice
• the proportion of H-Y-specific CD8+ T cells is increased 2- to 3-fold

endocrine/exocrine glands
• cell number within the thymus in male mice is decreased to a similar extent as in Tg(TcraH-Y,TcrbH-Y)71Vbo mice
• however, thymic negative selection is normal

cellular
• Vbeta8+/CD8+ T cell proliferation is increased

growth/size/body
• in male mice





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory